MS Management: The Immunosupression Debate- List the immunologic pathways that are involved in the pathophysiology of MS. Identify therapeutic agents that can block specific pathophysiologic pathways in MS. Identify the types of adverse events that may be associated with blocking immunologic pathways during MS treatment. Weigh the evidence that immunologically based agents can slow disease progression in MS. Choose appropriate therapy for patients with various presentations of MS, with an eye toward efficacy and long-term safety.
1.25 FREE contact hours for Nurse Practitioners, which includes 0.5 hours of pharmacology
Expires 12/31/11